Home » Concerns Raised about Tromethamine Contamination
Concerns Raised about Tromethamine Contamination
Rx-360
PharmaManufacturing.com
03/10/2010
Rx-360 reports: "Concerns have emerged recently from companies using Tromethamine, Tris Hydrochloride or Tris (Base) in their drug manufacturing processes due to issues caused by formaldehyde/para-formaldehyde contamination found in their products due to issues caused by formaldehyde/para-formaldehyde contamination found in the products that were sourced from certain areas of China."
Rx-360 will provide updates as they are available on its web site.
More News:
- 09/02/2010 SEC Nabs Merck Exec for Insider TradingFrom NYPost.com
- 09/02/2010 PBS: Behind FDA's Resource ChallengeFrom PBS.org
- 08/30/2010 Sanofi CEO: Genzyme is 'Stonewalling'From TheStreet.com
- 08/26/2010 115 Employees at Pfizer Will Lose Jobs in DecemberFrom RecordOnline.com
- 08/26/2010 Mexican Drug Gangs Target Pharma ShipmentsFrom SecuringPharma.com
- 08/26/2010 Lilly Manufacturing Facility Shutting Down, 140 People AffectedFrom MyCentralJersey.com
- 08/25/2010 Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
- 08/24/2010 Recall Fallout: FDA Puts Execs On NoticeFrom Money.CNN.com
- 08/19/2010 Dumped in a Parking Lot: How Pfizer Fires Sales Reps It Doesn't LikeFrom BNet.com
- 08/19/2010 Pharma's Contraction Leads to Outsourcing HiresFrom Portfolio.com
- All news »
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page